Overview

We all arose from one fertilized egg cell; in the precise and correct ratios, ~50 trillion cells arose from the division of one primitive cell. This requires incredible balance- too many divisions of the same clone equals cancer. The division of primitive cells that reside in human tissues must also strike this balance. By studying how molecules work together during the division of these cells, my group hopes to better detect, monitor, and treat the childhood and hereditary cancers that arise as a result of too many cell divisions and inflict 1,400 kids and 2,200 young adults each year in Canada.

Publications

The non-motor adaptor HMMR dampens Eg5-mediated forces to preserve the kinetics and integrity of chromosome segregation.
Molecular biology of the cell
Chen H and Connell M and Mei L and Reid GSD and Maxwell CA
DOI: 10.1091/mbc.E17-08-0531
PubMed: 29386294
01/2018

HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development.
eLife
Connell M and Chen H and Jiang J and Kuan CW and Fotovati A and Chu TL and He Z and Lengyell TC and Li H and Kroll T and Li AM and Goldowitz D and Frappart L and Ploubidou A and Patel MS and Maxwell CA
DOI: 10.7554/eLife.28672
PubMed: 28994651
10/2017

Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A.
Molecular cancer research : MCR
Chu TLH and Connell M and Zhou L and He Z and Won J and Chen H and Rahavi SMR and Mohan P and Nemirovsky O and Fotovati A and Pujana MA and Reid GSD and Nielsen TO and Pante N and Maxwell CA
DOI: 10.1158/1541-7786.mcr-17-0417
PubMed: 28993511
10/2017

BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells.
Oncotarget
He Z and Kannan N and Nemirovsky O and Chen H and Connell M and Taylor B and Jiang J and Pilarski LM and Fleisch MC and Niederacher D and Pujana MA and Eaves CJ and Maxwell CA
DOI: 10.18632/oncotarget.15688
PubMed: 28427147
05/2017

Genetic Instability
Reference Module in Biomedical Sciences
Meiyun Guo and Lin Mei and Christopher A. Maxwell
DOI: 10.1016/b978-0-12-801238-3.65013-4
2017

Anti-angiogenic treatment for breast cancer?
Cancer treatment reviews
van Netten JP and Cann SH and Thornton I and Finegan RP and Maxwell C
DOI: 10.1016/j.ctrv.2017.02.008
PubMed: 28320564
03/2017

Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.
Seminars in cancer biology
Ferguson LR and Chen H and Collins AR and Connell M and Damia G and Dasgupta S and Malhotra M and Meeker AK and Amedei A and Amin A and Ashraf SS and Aquilano K and Azmi AS and Bhakta D and Maxwell CA
DOI: 10.1016/j.semcancer.2015.03.005
PubMed: 25869442
04/2015

Genomic Instability and Cancer Metastasis
Cancer Metastasis - Biology and Treatment
DOI: 10.1007/978-3-319-12136-9
2015

Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2.
Cell cycle (Georgetown, Tex.)
Chen H and Mohan P and Jiang J and Nemirovsky O and He D and Fleisch MC and Niederacher D and Pilarski LM and Lim CJ and Maxwell CA
DOI: 10.4161/cc.29270
PubMed: 24875404
05/2014

Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling.
The Journal of pathology
Ferrer I and Mohan P and Chen H and Castellsague J and Gómez-Baldó L and Carmona M and García N and Aguilar H and Jiang J and Skowron M and Nellist M and Ampuero I and Russi A and Pujana MA
DOI: 10.1002/path.4343
PubMed: 24604753
04/2014

CD44-mediated hyaluronan binding marks proliferating hematopoietic progenitor cells and promotes bone marrow engraftment.
PloS one
Lee-Sayer SSM and Dougan MN and Cooper J and Sanderson L and Dosanjh M and Maxwell CA and Johnson P
DOI: 10.1371/journal.pone.0196011
PubMed: 29684048
04/2018

Hyaluronan-binding by CD44 reduces the memory potential of activated murine CD8 T cells.
European journal of immunology
Lee-Sayer SSM and Maeshima N and Dougan MN and Dahiya A and Arif AA and Dosanjh M and Maxwell CA and Johnson P
DOI: 10.1002/eji.201747263
PubMed: 29315518
01/2018

Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Seminars in cancer biology
Block KI and Gyllenhaal C and Lowe L and Amedei A and Amin ARMR and Amin A and Aquilano K and Arbiser J and Arreola A and Arzumanyan A and Ashraf SS and Azmi AS and Benencia F and Zollo M
DOI: 10.1016/j.semcancer.2015.09.007
PubMed: 26590477
12/2015

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
PloS one
Blanco I and Kuchenbaecker K and Cuadras D and Wang X and Barrowdale D and de Garibay GR and Librado P and Sánchez-Gracia A and Rozas J and Bonifaci N and McGuffog L and Pankratz VS and Pujana MA
DOI: 10.1371/journal.pone.0120020
PubMed: 25830658
04/2015

YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.
Stem cells (Dayton, Ohio)
Davies AH and Reipas KM and Pambid MR and Berns R and Stratford AL and Fotovati A and Firmino N and Astanehe A and Hu K and Maxwell C and Mills GB and Dunn SE
DOI: 10.1002/stem.1707
PubMed: 24648416
06/2014

The Generation, Detection, and Prevention of Genomic Instability During Cancer Progression and Metastasis
Genomic Instability and Cancer Metastasis
Helen Chen and Christopher Maxwell and Marisa Connell
DOI: 10.1007/978-3-319-12136-9_2
2014

The cytoskeletal protein RHAMM and ERK1/2 activity maintain the pluripotency of murine embryonic stem cells.
PloS one
Jiang J and Mohan P and Maxwell CA
DOI: 10.1371/journal.pone.0073548
PubMed: 24019927
09/2013

Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
Oncotarget
Mohan P and Castellsague J and Jiang J and Allen K and Chen H and Nemirovsky O and Spyra M and Hu K and Kluwe L and Pujana MA and Villanueva A and Mautner VF and Keats JJ and Dunn SE and Maxwell CA
DOI: 10.18632/oncotarget.793
PubMed: 23328114
01/2013

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
PLoS biology
Maxwell CA and Benítez J and Gómez-Baldó L and Osorio A and Bonifaci N and Fernández-Ramires R and Costes SV and Guinó E and Chen H and Evans GJ and Mohan P and Català I and Petit A and Pujana MA
DOI: 10.1371/journal.pbio.1001199
PubMed: 22110403
11/2011

Exploring the link between MORF4L1 and risk of breast cancer.
Breast cancer research : BCR
Martrat G and Maxwell CM and Tominaga E and Porta-de-la-Riva M and Bonifaci N and Gómez-Baldó L and Bogliolo M and Lázaro C and Blanco I and Brunet J and Aguilar H and Pujana MA
DOI: 10.1186/bcr2862
PubMed: 21466675
04/2011

YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification.
Oncogene
Davies AH and Barrett I and Pambid MR and Hu K and Stratford AL and Freeman S and Berquin IM and Pelech S and Hieter P and Maxwell C and Dunn SE
DOI: 10.1038/onc.2011.82
PubMed: 21423216
03/2011

Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.
Expert reviews in molecular medicine
Stratford AL and Reipas K and Maxwell C and Dunn SE
DOI: 10.1017/s1462399410001535
PubMed: 20653987
07/2010

Multifunctional proteins bridge mitosis with motility and cancer with inflammation and arthritis.
TheScientificWorldJournal
Jiang J and Casalegno-Garduno R and Chen H and Schmitt A and Schmitt M and Maxwell CA
DOI: 10.1100/tsw.2010.141
PubMed: 20602082
06/2010

TACC3-TSC2 maintains nuclear envelope structure and controls cell division.
Cell cycle (Georgetown, Tex.)
Gómez-Baldó L and Schmidt S and Maxwell CA and Bonifaci N and Gabaldón T and Vidalain PO and Senapedis W and Kletke A and Rosing M and Barnekow A and Rottapel R and Capellá G and Pujana MA
DOI: 10.4161/cc.9.6.11018
PubMed: 20237422
03/2010

Biological convergence of cancer signatures.
PloS one
Solé X and Bonifaci N and López-Bigas N and Berenguer A and Hernández P and Reina O and Maxwell CA and Aguilar H and Urruticoechea A and de Sanjosé S and Comellas F and Capellá G and Pujana MA
DOI: 10.1371/journal.pone.0004544
PubMed: 19229342
02/2009

Targeted and nontargeted effects of ionizing radiation that impact genomic instability.
Cancer research
Maxwell CA and Fleisch MC and Costes SV and Erickson AC and Boissière A and Gupta R and Ravani SA and Parvin B and Barcellos-Hoff MH
DOI: 10.1158/0008-5472.can-08-1212
PubMed: 18922902
10/2008

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
Journal of cell science
Maxwell CA and McCarthy J and Turley E
DOI: 10.1242/jcs.022038
PubMed: 18354082
04/2008

Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells.
Leukemia & lymphoma
Evans R and Naber C and Steffler T and Checkland T and Keats J and Maxwell C and Perry T and Chau H and Belch A and Pilarski L and Reiman T
DOI: 10.1080/10428190701824544
PubMed: 18297535
03/2008

Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.
BMC genomics
Solé X and Hernández P and de Heredia ML and Armengol L and Rodríguez-Santiago B and Gómez L and Maxwell CA and Aguiló F and Condom E and Abril J and Pérez-Jurado L and Estivill X and Pujana MA
DOI: 10.1186/1471-2164-9-12
PubMed: 18190704
01/2008

Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment.
Molecular cancer
Maxwell CA and Moreno V and Solé X and Gómez L and Hernández P and Urruticoechea A and Pujana MA
DOI: 10.1186/1476-4598-7-4
PubMed: 18186929
01/2008

The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.
British journal of haematology
Evans RP and Naber C and Steffler T and Checkland T and Maxwell CA and Keats JJ and Belch AR and Pilarski LM and Lai R and Reiman T
DOI: 10.1111/j.1365-2141.2007.06913.x
PubMed: 18076711
12/2007

Targeting aurora kinases as therapy in multiple myeloma.
Blood
Shi Y and Reiman T and Li W and Maxwell CA and Sen S and Pilarski L and Daniels TR and Penichet ML and Feldman R and Lichtenstein A
DOI: 10.1182/blood-2006-07-037671
PubMed: 17213289
01/2007

Geometric approach to segmentation and protein localization in cell culture assays.
Journal of microscopy
Raman S and Maxwell CA and Barcellos-Hoff MH and Parvin B
DOI: 10.1111/j.1365-2818.2007.01712.x
PubMed: 17286692
01/2007

Intensity-based signal separation algorithm for accurate quantification of clustered centrosomes in tissue sections.
Microscopy research and technique
Fleisch MC and Maxwell CA and Kuper CK and Brown ET and Barcellos-Hoff MH and Costes SV
DOI: 10.1002/jemt.20372
PubMed: 16941664
12/2006

The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs.
Endocrine-related cancer
Fleisch MC and Maxwell CA and Barcellos-Hoff MH
DOI: 10.1677/erc.1.01112
PubMed: 16728569
06/2006

Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer.
Current drug targets. Cardiovascular & haematological disorders
Adamia S and Maxwell CA and Pilarski LM
DOI: 10.2174/1568006053005056
PubMed: 15720220
02/2005

Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity.
Cancer research
Maxwell CA and Keats JJ and Belch AR and Pilarski LM and Reiman T
PubMed: 15705883
02/2005

Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
Blood
Keats JJ and Maxwell CA and Taylor BJ and Hendzel MJ and Chesi M and Bergsagel PL and Larratt LM and Mant MJ and Reiman T and Belch AR and Pilarski LM
DOI: 10.1182/blood-2004-09-3704
PubMed: 15677557
01/2005

A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
Medical hypotheses
Maxwell CA and Pilarski LM
DOI: 10.1016/j.mehy.2005.05.031
PubMed: 16023302
01/2005

RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.
Blood
Maxwell CA and Rasmussen E and Zhan F and Keats JJ and Adamia S and Strachan E and Crainie M and Walker R and Belch AR and Pilarski LM and Barlogie B and Shaughnessy J and Reiman T
DOI: 10.1182/blood-2003-11-4079
PubMed: 15105292
04/2004

Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications.
Cancer research
Mitsiades CS and Mitsiades NS and Bronson RT and Chauhan D and Munshi N and Treon SP and Maxwell CA and Pilarski L and Hideshima T and Hoffman RM and Anderson KC
PubMed: 14583463
10/2003

RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability.
Molecular biology of the cell
Maxwell CA and Keats JJ and Crainie M and Sun X and Yen T and Shibuya E and Hendzel M and Chan G and Pilarski LM
DOI: 10.1091/mbc.E02-07-0377
PubMed: 12808028
03/2003

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.
Blood
Keats JJ and Reiman T and Maxwell CA and Taylor BJ and Larratt LM and Mant MJ and Belch AR and Pilarski LM
DOI: 10.1182/blood-2002-06-1675
PubMed: 12393535
10/2002

The integration of tissue structure and nuclear function.
Biochemistry and cell biology = Biochimie et biologie cellulaire
Maxwell CA and Hendzel MJ
DOI: 10.1139/o01-078
PubMed: 11467740
01/2001

Lymphagenesis and cancer metastasis.
British journal of cancer
van Netten JP and Cann SA and Maxwell CA and Finegan RP
DOI: 10.1038/bjc.1998.481
PubMed: 9683308
07/1998

Research

Current Projects
The objectives for my research program are to more completely understand cell division at a molecular level and apply that knowledge to the study of cells that maintain the growth and development of the human brain and breast. We focus on a small set of key genes and study how their products are involved in human development and cancer using a variety of systems, including cells that grow indefinitely in the lab, mice, flies, and human tissues from both healthy and diseased individuals.

Grants

The Maxwell lab is a member of the Michael Cuccione Childhood Cancer Research program. We currently receive research funding support from the following organizations: Avon Foundation, Canadian Breast Cancer Foundation, Canadian Institutes of Health Research (CIHR), Michael Cuccione Childhood Cancer Foundation. We are very grateful for their support.

Honours & Awards

2014-2019: New Investigator, NIC category, CIHR

Research Group Members

Edward Morris, Research Technician
Tony Lok Heng Chu, Doctoral Student
Zhengcheng (Leo) He, Doctoral Student
Brenda Tse, Research Coordinator
Amanda Lorentzian, Graduate student
Meiyun Guo, Graduate student
Lin Mei, Graduate Student